- Revenue
- 109.6 M EUR
- FY 2024
- Total assets
- 102,993,470 EUR
- FY 2024
- Filed years
- 3
- 2022 - 2024
Identity
- Identifier
- 237549M
- Sector
- Drugs (pharmaceutical)
- Sector group
- Health & Life Sciences
- NACE code
- 21 · Industrie pharmaceutique
- Activity (registry)
- Industrie pharmaceutique
- Listed
- No
Source: Firmenbuch. Statutory filing data; verify on the registry for any critical use.
Financial statements
Detailed balance sheet and income statement, every filed year
Account required. The Discovery plan is free: detailed financial statements, 5 results per search, 2 Excel exports of 25 rows per month, 50 API calls per day.
Create a free accountNo card required.